OpenFilings

Vir Biotechnology, Inc.

Form10-K

Report Period2024-12-31

Date Filed2025-02-27

Time Filed17:34:44

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
EX-10.8 NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
EX-10.9 DISCRETIONARY BONUS PLAN
EX-10.12 PROMOTION LETTER (VANINA DE VERNEUIL)
EX-10.13 OFFER LETTER (MARK EISNER)
EX-10.15 CHANGE IN CONTROL AND SEVERANCE BENEFIT PLAN
EX-19 INSIDER TRADING POLICY
EX-21.1 SUBSIDIARIES
EX-23.1 EY CONSENT
EX-31.1
EX-31.2
EX-32.1
GRAPHIC_PIPELINE
GRAPHIC_MECHANISM OF TOBEVIBART AND ELEBSIRAN
GRAPHIC_MABS AND TCES SIMILARITIES
GRAPHIC_MAB DISCOVERY WORKFLOW
GRAPHIC_MASKING MOA
GRAPHIC_TCE STRUCTURE
GRAPHIC_COMPARISON OF CUMULATIVE TOTAL RETURNS
Filing on SEC Edgar